Literature DB >> 9949160

Lineage-restricted expression of protein kinase C isoforms in hematopoiesis.

A Bassini1, G Zauli, G Migliaccio, A R Migliaccio, M Pascuccio, S Pierpaoli, L Guidotti, S Capitani, M Vitale.   

Abstract

The pattern of expression of several protein kinase C (PKC) isoforms (alpha, betaI, delta, epsilon, eta, and zeta) during the course of hematopoietic development was investigated using primary human CD34(+) hematopoietic cells and stable cell lines subcloned from the growth factor-dependent 32D murine hematopoietic cell line. Each 32D cell clone shows the phenotype and growth factor dependence characteristics of the corresponding hematopoietic lineage. Clear-cut differences were noticed between erythroid and nonerythroid lineages. (1) The functional inhibition of PKC-epsilon in primary human CD34(+) hematopoietic cells resulted in a twofold increase in the number of erythroid colonies. (2) Erythroid 32D Epo1 cells showed a lower level of bulk PKC catalytic activity, lacked the expression of epsilon and eta PKC isoforms, and showed a weak or absent upregulation of the remaining isoforms, except betaI, upon readdition of Epo to growth factor-starved cells. (3) 32D, 32D GM1, and 32D G1 cell lines with mast cell, granulo-macrophagic, and granulocytic phenotype, respectively, expressed all the PKC isoforms investigated, but showed distinct responses to growth factor readdition. (4) 32D Epo 1.1, a clone selected for interleukin-3 (IL-3) responsiveness from 32D Epo1, expressed the epsilon isoform only when cultured with IL-3. On the other hand, when cultured in Epo, 32D Epo1.1 cells lacked the expression of both epsilon and eta PKC isoforms, similarly to 32D Epo1. (5) All 32D cell lines expressed the mRNA for PKC-epsilon, indicating that the downmodulation of the epsilon isoform occurred at a posttranscriptional level. In conclusion, the PKC isoform expression during hematopoiesis appears to be lineage-specific and, at least partially, related to the growth factor response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949160

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple.

Authors:  Cecilia Carubbi; Elena Masselli; Silvia Martini; Daniela Galli; Franco Aversa; Prisco Mirandola; Joseph E Italiano; Giuliana Gobbi; Marco Vitale
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

2.  The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Authors:  Julia E Gambone; Stephanie S Dusaban; Roxana Loperena; Yuji Nakata; Susan E Shetzline
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

3.  Iron control of erythroid development by a novel aconitase-associated regulatory pathway.

Authors:  Grant C Bullock; Lorrie L Delehanty; Anne-Laure Talbot; Sara L Gonias; Wing-Hang Tong; Tracey A Rouault; Brian Dewar; Jeffrey M Macdonald; Jason J Chruma; Adam N Goldfarb
Journal:  Blood       Date:  2010-04-20       Impact factor: 22.113

4.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

5.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

6.  Distinctive requirement of PKCε in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells.

Authors:  Victoria Casado-Medrano; Laura Barrio-Real; Anita Wang; Mariana Cooke; Cynthia Lopez-Haber; Marcelo G Kazanietz
Journal:  Oncogene       Date:  2019-03-28       Impact factor: 9.867

7.  A cancer-associated, genome protective programme engaging PKCε.

Authors:  Peter J Parker; Nicola Lockwood; Khalil Davis; Joanna R Kelly; Tanya N Soliman; Ainara Lopez Pardo; Jacqueline J T Marshall; Joanna M Redmond; Marco Vitale
Journal:  Adv Biol Regul       Date:  2020-10-07

Review 8.  ROS in Platelet Biology: Functional Aspects and Methodological Insights.

Authors:  Elena Masselli; Giulia Pozzi; Mauro Vaccarezza; Prisco Mirandola; Daniela Galli; Marco Vitale; Cecilia Carubbi; Giuliana Gobbi
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

9.  Unique in vitro and in vivo thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca(++)-independent protein kinase C isoform agonist.

Authors:  Frederick K Racke; Maureen Baird; Rolf F Barth; Tianyao Huo; Weilian Yang; Nilendu Gupta; Michael Weldon; Heather Rutledge
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Protein kinase C ε expression in platelets from patients with acute myocardial infarction.

Authors:  Cecilia Carubbi; Prisco Mirandola; Maria Mattioli; Daniela Galli; Nicola Marziliano; Piera Angelica Merlini; Daniela Lina; Francesca Notarangelo; Maria Rita Cozzi; Marco Gesi; Diego Ardissino; Luigi De Marco; Marco Vitale; Giuliana Gobbi
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.